Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model. - Wikidata - wikimedia - TriplyDB

Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model.

Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model.

http://www.wikidata.org/entity/Q44003999

about

Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage Current perspective of neuroprotection and glaucoma Caspase inhibition with XIAP as an adjunct to AAV vector gene-replacement therapy: improving efficacy and prolonging the treatment window XIAP protection of photoreceptors in animal models of retinitis pigmentosa.Effect of CNTF on retinal ganglion cell survival in experimental glaucoma Recent advances in pharmacotherapy of glaucoma Gene therapy targeting glaucoma: where are we?Calcineurin cleavage is triggered by elevated intraocular pressure, and calcineurin inhibition blocks retinal ganglion cell death in experimental glaucoma Minocycline is cytoprotective in human trabecular meshwork cells and optic nerve head astrocytes by increasing expression of XIAP, survivin, and Bcl-2.Quantitative analysis of retinal ganglion cell survival with Rbpms immunolabeling in animal models of optic neuropathies.Gene therapy in glaucoma-3: Therapeutic approaches.Regulation of nitric oxide production by δ-opioid receptors during glaucomatous injury.Endothelin B receptors contribute to retinal ganglion cell loss in a rat model of glaucoma.Acetylation preserves retinal ganglion cell structure and function in a chronic model of ocular hypertension.Disease progression in iridocorneal angle tissues of BMP2-induced ocular hypertensive mice with optical coherence tomography.Celastrol supports survival of retinal ganglion cells injured by optic nerve crush.Induction of autophagy in rats upon overexpression of wild-type and mutant optineurin gene.Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences.Gene therapy for optic nerve disease.New paradigms in the mechanisms and management of glaucoma.Preservation of retina ganglion cell function by morphine in a chronic ocular-hypertensive rat model.Immunoproteomic analysis of potential serum biomarker candidates in human glaucoma.Method validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linked inhibitor of apoptosis protein XIAP.AAV-mediated gene transfer for retinal diseases.Delta-opioid agonist SNC-121 protects retinal ganglion cell function in a chronic ocular hypertensive rat model.Heat shock proteins in the retina: Focus on HSP70 and alpha crystallins in ganglion cell survival.XIAP effects on retinal detachment-induced photoreceptor apoptosis [corrected].Advances in Gene Therapy for Diseases of the Eye.Family-based analysis identified CD2 as a susceptibility gene for primary open angle glaucoma in Chinese Han population.Gene therapy for retinal ganglion cell neuroprotection in glaucoma.Preclinical models to investigate retinal ischemia: advances and drawbacks.Challenges in neuroprotective nanomedicine development: progress towards noninvasive gene therapy of glaucoma.Development of diagnostic and treatment strategies for glaucoma through understanding and modification of scleral and lamina cribrosa connective tissue Neuroprotective therapies for glaucoma.The Pathway From Genes to Gene Therapy in Glaucoma: A Review of Possibilities for Using Genes as Glaucoma Drugs.Overexpression of Soluble Fas Ligand following Adeno-Associated Virus Gene Therapy Prevents Retinal Ganglion Cell Death in Chronic and Acute Murine Models of Glaucoma.Overexpression of the X-Linked Inhibitor of Apoptosis Protects Against Retinal Degeneration in a Feline Model of Retinal Detachment.Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAP.Effect of GDNF gene transfer into axotomized retinal ganglion cells using in vivo electroporation with a contact lens-type electrode.Gene and protein expression pilot profiling and biomarkers in an experimental mouse model of hypertensive glaucoma.

P2860

Q24811545-AD3A9B21-A052-4CEB-A6D5-C32518DCA332 Q26774852-4DF4192A-C58A-48A1-AEA6-B0E77933710A Q28729935-89C78E9E-2B8B-49BB-BB07-246B272474DD Q33279531-FA180E18-4A97-441E-AFBD-3A084085F798 Q33390314-5D7CE40B-A73D-4A80-8269-6A16408F5720 Q33521178-4C4CE49F-DFE8-4E11-9EC3-3D9E467C506E Q33763673-16B45154-7020-4471-8B6A-C12790A75607 Q33917505-04F07FE6-9D55-49C8-84D7-6604F20116BC Q34019667-747ECD9F-D760-41C3-83F7-AC48652A8D0E Q34081250-E828378F-B6C3-4B8D-8809-377484097438 Q34351545-C0057AEE-49E3-43B7-A73C-5A869D102EE6 Q34362259-1D08ECB3-E39D-4718-A372-B67B90BC4289 Q34391403-18514F01-5BA0-4979-BAB2-B28B7B48907A Q34557844-60F15567-76AE-4AF1-8489-6F832490189F Q34787079-8A0474A7-6643-4D58-8BFF-2520E5E40332 Q35562982-AF384254-6BF1-432D-8A44-B9585CB2C8E9 Q35599430-12D501E8-4B18-4FBC-81B3-86BE88C03416 Q35677091-45AC9DB2-52FE-4846-8CA8-669B1B8CAA49 Q35943998-389EA0A8-6C4E-4768-B344-65758D48C7F4 Q35949074-63E6CCB3-F8D5-49C1-8E47-A89C2ABD12E4 Q36082789-12DBED51-A056-491F-862C-721B21CD9F74 Q36467223-C126E638-C048-444E-99A6-E88390B073D2 Q36611534-AA15BC5A-85B4-4233-BD53-FBE1AAB31D3A Q36708300-456EFDDA-C9F0-49AB-A007-672AB2223C44 Q36766592-B040EB96-73F3-400E-9751-77A5F0EF7EB1 Q36829093-6A03D110-55F3-4AA6-AA19-AC1D444BAD54 Q37024493-F34CE340-2783-49E8-A3FA-127EDD220FA6 Q37190609-8317C5ED-EF5D-4A15-B22A-D74A6EF2370F Q37724017-07926A53-5FB1-4821-8AEC-0F4A0A68D8AB Q37942753-DB373202-AE91-46BC-8764-A724E9B03150 Q38010704-BD1EC658-F6B1-4C5C-9E67-D19AEEC1C8CE Q38030642-4BC5BCD5-50F6-4B34-AEF8-EAC057DAE756 Q38093773-482F14C1-E29E-41DC-AA90-04BCF1315C7C Q38384978-E11D1B90-ADF9-4EBE-83BD-DE9CC2E95D96 Q38761425-AEFA0B14-1B3A-4408-B733-4991FFCF1838 Q39184214-9D1543CF-C71B-4C68-81F8-7900ADF8DE4C Q40277288-075B1070-EF7F-412B-AF7F-53CA9B43D7F1 Q40463082-C63C407F-CBD7-436F-966F-21B28C539C53 Q40477606-8CD14206-E480-4C96-ADD4-86F82759BF2F Q41411098-B6668DFE-F538-43B9-BA8B-7302D1DE7F41

P2860

Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model.

http://www.wikidata.org/entity/Q44003999

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model.

@en

Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model.

@nl

type

label

Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model.

@en

Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model.

@nl

prefLabel

Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model.

@en

Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model.

@nl

P1433

Q44003999-DE87C79E-2DBC-48E7-8BF1-F5659ABF20B6

P1476

Q44003999-554BB4AC-70A2-4F64-85AC-98A9AF3BAC57

P2093

Q44003999-09B92E00-13CA-443F-AAEA-26C54E7AADF5

Q44003999-5D9B4067-510B-4686-9583-A937AE8BE3EC

Q44003999-69E15BC3-2F85-4CBE-B320-7DB6AB98D128

Q44003999-7A9ECDB5-1191-4551-A4E0-F158D52F1EF0

Q44003999-7F056E21-AD91-4DDC-BC43-D2FBB95A419B

Q44003999-B4BBA59E-09AF-4E36-BC5B-E61A91232F8C

Q44003999-CAD369FB-5BDD-43C8-B2C6-41211AB5970E

Q44003999-D19FC78C-8471-48BA-8F8F-F60D2189F503

Q44003999-D50CA542-6F97-40A2-ADAD-D0C7D6B584A4

Q44003999-DA6E21C3-F2AF-4A87-99DC-FD2616AF6C23

P304

Q44003999-0194EF73-A7E9-4219-A84C-1523DBEF7A40

P31

Q44003999-898EE415-6D93-4819-B79E-33A20745B755

P356

Q44003999-618D6B1E-4371-41BC-AAAE-1671FDDC011C

P433

Q44003999-ABD7EE16-BA57-42EC-813C-DC7AC7E0513C

P478

Q44003999-E4451A01-C9B8-4B07-BB75-F32B0BFDC892

P577

Q44003999-D52EEFCD-54DC-45D4-885F-13862F8701CE

P5875

Q44003999-59317DE3-23FE-4415-AA34-FA511E3CBB69

P698

Q44003999-74282D50-5A1F-4627-A40C-2BA5F9A9C5D3

P356

P1433

Molecular Therapy

P1476

Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model.

@en

P2093

Donna M Lehman

http://www.w3.org/2001/XMLSchema#string

Eric LaCasse

http://www.w3.org/2001/XMLSchema#string

Herbert A Reitsamer

http://www.w3.org/2001/XMLSchema#string

N Grace Tahzib

http://www.w3.org/2001/XMLSchema#string

Nancy L Ransom

http://www.w3.org/2001/XMLSchema#string

Peter Liston

http://www.w3.org/2001/XMLSchema#string

Qiuhong Li

http://www.w3.org/2001/XMLSchema#string

Robert G Korneluk

http://www.w3.org/2001/XMLSchema#string

Stuart J McKinnon

http://www.w3.org/2001/XMLSchema#string

William W Hauswirth

http://www.w3.org/2001/XMLSchema#string

P304

780-787

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1006/MTHE.2002.0608

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2002-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11343944

http://www.w3.org/2001/XMLSchema#string

P698

12027563

http://www.w3.org/2001/XMLSchema#string